Clinical Evidence


Delve into clinical research studies and more 

Clinical research lies at the heart of who we are. Vantive uses scientific evidence systematically and transparently, to inform the development of state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Vantive.

254 results

HDx therapy enabled by Theranova
Performance of medium cut-off dialyzers in expanded hemodialysis patients in Colombia
PD
Perspectives from the Kidney Health Initiative on Advancing Technologies to Facilitate Remote Monitoring of Patient Self-Care in RRT - Rosner et al.
HDx therapy enabled by Theranova
Prevalence of fatigue reported by patients on hemodialysis therapy
HDx therapy enabled by Theranova
Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study
HDx therapy enabled by Theranova
Protein bound drug removal by membranes of different albumin permeability
HDx therapy enabled by Theranova
Protein loss and medium cut-off haemodialysis
HDx therapy enabled by Theranova
Pruritus: Is there a grain of salty truth?
HDx therapy enabled by Theranova
Pushing the boundaries of hemodialysis: innovations in membranes and sorbents
HDx therapy enabled by Theranova
Pyrogen retention: Comparison of the novel medium cut-off (MCO) membrane with other dialyser membranes
HDx therapy enabled by Theranova
Quantification of Internal Filtration in Hollow Fiber Hemodialyzers with Medium Cut-Off Membrane
HDx therapy enabled by Theranova
Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis
HDx therapy enabled by Theranova
Rationale for Medium Cutoff Membranes in COVID-19 Patients Requiring Renal Replacement Therapy

Vantive is a trademark of Vantive Health LLC or its affiliates.